Physician profile
Tyson Carter
NPI 1578902896
$6,296.66
in general payments reported to CMS, 2019-2025
16 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,973 · 2020: $792 · 2021: $450 · 2022: $403 · 2024: $478 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $430 · Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $430.20 |
| Food and Beverage | $248.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,709.40 | 2019 | |
| Arthrosurface Incorporated | $883.75 | 2019 | |
| Osteomed LLC | $776.25 | 2019 | |
| Stryker Corporation | $518.18 | 2019-2024 | N/A |
| Medical Device Business Services, INC. | $489.72 | 2020 | |
| Treace Medical Concepts, INC. | $430.20 | 2024 | |
| Anika Therapeutics, INC. | $322.20 | 2022 | |
| Active Medical, LLC | $212.60 | 2019 | |
| Sanara Medtech INC. | $212.25 | 2021 | |
| Organogenesis INC. | $154.59 | 2020 | |
| Bone Support INC. | $144.89 | 2025 | Cerament G, Ceramentbone Void Filler |
| Heron Therapeutics, INC. | $121.84 | 2021 | |
| Bioventus LLC | $116.18 | 2021 | |
| Imbed Biosciences INC. | $80.91 | 2022 | |
| Fusion Orthopedics, LLC. | $68.32 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $55.38 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyson Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.